0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Continuous Blood Glucose Monitoring Systems Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-17I7099
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Continuous Blood Glucose Monitoring Systems Market Insights and Forecast to 2028
BUY CHAPTERS

Global Continuous Blood Glucose Monitoring Systems Market Research Report 2025

Code: QYRE-Auto-17I7099
Report
August 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Continuous Blood Glucose Monitoring Systems Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Continuous Blood Glucose Monitoring Systems Market

Continuous Blood Glucose Monitoring Systems Market

The global market for Continuous Blood Glucose Monitoring Systems was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A CGM system provides continuous insight into glucose levels throughout the day and night. The device displays information about glucose direction and rate of change providing users additional information to help with their diabetes management. Studies have shown that CGM systems may help reduce your A1C and reduce your risk for hypoglycemia, whether you are on insulin injections or pump Therapy.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Continuous Blood Glucose Monitoring Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Blood Glucose Monitoring Systems.
The Continuous Blood Glucose Monitoring Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Continuous Blood Glucose Monitoring Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Blood Glucose Monitoring Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Continuous Blood Glucose Monitoring Systems Market Report

Report Metric Details
Report Name Continuous Blood Glucose Monitoring Systems Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • Self/Home Care
  • Hospital & Clinics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, F. Hoffmann-La Roche, Lifescan, Ascensia Diabetes Care, Dexcom, Medtronic, Ypsomed, B. Braun Melsungen, Nipro, Sanofi, Arkray, Prodigy Diabetes Care, Acon Laboratories, Nova Biomedical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Continuous Blood Glucose Monitoring Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Continuous Blood Glucose Monitoring Systems Market report?

Ans: The main players in the Continuous Blood Glucose Monitoring Systems Market are Abbott Laboratories, F. Hoffmann-La Roche, Lifescan, Ascensia Diabetes Care, Dexcom, Medtronic, Ypsomed, B. Braun Melsungen, Nipro, Sanofi, Arkray, Prodigy Diabetes Care, Acon Laboratories, Nova Biomedical

What are the Application segmentation covered in the Continuous Blood Glucose Monitoring Systems Market report?

Ans: The Applications covered in the Continuous Blood Glucose Monitoring Systems Market report are Self/Home Care, Hospital & Clinics

What are the Type segmentation covered in the Continuous Blood Glucose Monitoring Systems Market report?

Ans: The Types covered in the Continuous Blood Glucose Monitoring Systems Market report are Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems

Recommended Reports

CGM and Glucose Monitors

Home & Portable Glucose Meters

Blood Glucose Testing Systems

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Self-Monitoring Blood Glucose Systems
1.2.3 Continuous Glucose Monitoring Systems
1.3 Market by Application
1.3.1 Global Continuous Blood Glucose Monitoring Systems Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Self/Home Care
1.3.3 Hospital & Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Continuous Blood Glucose Monitoring Systems Market Perspective (2020-2031)
2.2 Global Continuous Blood Glucose Monitoring Systems Growth Trends by Region
2.2.1 Global Continuous Blood Glucose Monitoring Systems Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Continuous Blood Glucose Monitoring Systems Historic Market Size by Region (2020-2025)
2.2.3 Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Region (2026-2031)
2.3 Continuous Blood Glucose Monitoring Systems Market Dynamics
2.3.1 Continuous Blood Glucose Monitoring Systems Industry Trends
2.3.2 Continuous Blood Glucose Monitoring Systems Market Drivers
2.3.3 Continuous Blood Glucose Monitoring Systems Market Challenges
2.3.4 Continuous Blood Glucose Monitoring Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Continuous Blood Glucose Monitoring Systems Players by Revenue
3.1.1 Global Top Continuous Blood Glucose Monitoring Systems Players by Revenue (2020-2025)
3.1.2 Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Players (2020-2025)
3.2 Global Continuous Blood Glucose Monitoring Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Continuous Blood Glucose Monitoring Systems Revenue
3.4 Global Continuous Blood Glucose Monitoring Systems Market Concentration Ratio
3.4.1 Global Continuous Blood Glucose Monitoring Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Continuous Blood Glucose Monitoring Systems Revenue in 2024
3.5 Global Key Players of Continuous Blood Glucose Monitoring Systems Head office and Area Served
3.6 Global Key Players of Continuous Blood Glucose Monitoring Systems, Product and Application
3.7 Global Key Players of Continuous Blood Glucose Monitoring Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Continuous Blood Glucose Monitoring Systems Breakdown Data by Type
4.1 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Type (2020-2025)
4.2 Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Type (2026-2031)
5 Continuous Blood Glucose Monitoring Systems Breakdown Data by Application
5.1 Global Continuous Blood Glucose Monitoring Systems Historic Market Size by Application (2020-2025)
5.2 Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Continuous Blood Glucose Monitoring Systems Market Size (2020-2031)
6.2 North America Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2020-2025)
6.4 North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Continuous Blood Glucose Monitoring Systems Market Size (2020-2031)
7.2 Europe Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2020-2025)
7.4 Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size (2020-2031)
8.2 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2020-2025)
8.4 Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Continuous Blood Glucose Monitoring Systems Market Size (2020-2031)
9.2 Latin America Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2020-2025)
9.4 Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size (2020-2031)
10.2 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2020-2025)
10.4 Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Continuous Blood Glucose Monitoring Systems Introduction
11.1.4 Abbott Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Continuous Blood Glucose Monitoring Systems Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Lifescan
11.3.1 Lifescan Company Details
11.3.2 Lifescan Business Overview
11.3.3 Lifescan Continuous Blood Glucose Monitoring Systems Introduction
11.3.4 Lifescan Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.3.5 Lifescan Recent Development
11.4 Ascensia Diabetes Care
11.4.1 Ascensia Diabetes Care Company Details
11.4.2 Ascensia Diabetes Care Business Overview
11.4.3 Ascensia Diabetes Care Continuous Blood Glucose Monitoring Systems Introduction
11.4.4 Ascensia Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.4.5 Ascensia Diabetes Care Recent Development
11.5 Dexcom
11.5.1 Dexcom Company Details
11.5.2 Dexcom Business Overview
11.5.3 Dexcom Continuous Blood Glucose Monitoring Systems Introduction
11.5.4 Dexcom Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.5.5 Dexcom Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Continuous Blood Glucose Monitoring Systems Introduction
11.6.4 Medtronic Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.6.5 Medtronic Recent Development
11.7 Ypsomed
11.7.1 Ypsomed Company Details
11.7.2 Ypsomed Business Overview
11.7.3 Ypsomed Continuous Blood Glucose Monitoring Systems Introduction
11.7.4 Ypsomed Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.7.5 Ypsomed Recent Development
11.8 B. Braun Melsungen
11.8.1 B. Braun Melsungen Company Details
11.8.2 B. Braun Melsungen Business Overview
11.8.3 B. Braun Melsungen Continuous Blood Glucose Monitoring Systems Introduction
11.8.4 B. Braun Melsungen Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.8.5 B. Braun Melsungen Recent Development
11.9 Nipro
11.9.1 Nipro Company Details
11.9.2 Nipro Business Overview
11.9.3 Nipro Continuous Blood Glucose Monitoring Systems Introduction
11.9.4 Nipro Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.9.5 Nipro Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Continuous Blood Glucose Monitoring Systems Introduction
11.10.4 Sanofi Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Arkray
11.11.1 Arkray Company Details
11.11.2 Arkray Business Overview
11.11.3 Arkray Continuous Blood Glucose Monitoring Systems Introduction
11.11.4 Arkray Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.11.5 Arkray Recent Development
11.12 Prodigy Diabetes Care
11.12.1 Prodigy Diabetes Care Company Details
11.12.2 Prodigy Diabetes Care Business Overview
11.12.3 Prodigy Diabetes Care Continuous Blood Glucose Monitoring Systems Introduction
11.12.4 Prodigy Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.12.5 Prodigy Diabetes Care Recent Development
11.13 Acon Laboratories
11.13.1 Acon Laboratories Company Details
11.13.2 Acon Laboratories Business Overview
11.13.3 Acon Laboratories Continuous Blood Glucose Monitoring Systems Introduction
11.13.4 Acon Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.13.5 Acon Laboratories Recent Development
11.14 Nova Biomedical
11.14.1 Nova Biomedical Company Details
11.14.2 Nova Biomedical Business Overview
11.14.3 Nova Biomedical Continuous Blood Glucose Monitoring Systems Introduction
11.14.4 Nova Biomedical Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
11.14.5 Nova Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Self-Monitoring Blood Glucose Systems
 Table 3. Key Players of Continuous Glucose Monitoring Systems
 Table 4. Global Continuous Blood Glucose Monitoring Systems Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Continuous Blood Glucose Monitoring Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Continuous Blood Glucose Monitoring Systems Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Continuous Blood Glucose Monitoring Systems Market Share by Region (2020-2025)
 Table 8. Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Continuous Blood Glucose Monitoring Systems Market Share by Region (2026-2031)
 Table 10. Continuous Blood Glucose Monitoring Systems Market Trends
 Table 11. Continuous Blood Glucose Monitoring Systems Market Drivers
 Table 12. Continuous Blood Glucose Monitoring Systems Market Challenges
 Table 13. Continuous Blood Glucose Monitoring Systems Market Restraints
 Table 14. Global Continuous Blood Glucose Monitoring Systems Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Continuous Blood Glucose Monitoring Systems Market Share by Players (2020-2025)
 Table 16. Global Top Continuous Blood Glucose Monitoring Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Blood Glucose Monitoring Systems as of 2024)
 Table 17. Ranking of Global Top Continuous Blood Glucose Monitoring Systems Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Continuous Blood Glucose Monitoring Systems Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Continuous Blood Glucose Monitoring Systems, Headquarters and Area Served
 Table 20. Global Key Players of Continuous Blood Glucose Monitoring Systems, Product and Application
 Table 21. Global Key Players of Continuous Blood Glucose Monitoring Systems, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Continuous Blood Glucose Monitoring Systems Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Type (2020-2025)
 Table 25. Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Type (2026-2031)
 Table 27. Global Continuous Blood Glucose Monitoring Systems Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Application (2020-2025)
 Table 29. Global Continuous Blood Glucose Monitoring Systems Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Continuous Blood Glucose Monitoring Systems Revenue Market Share by Application (2026-2031)
 Table 31. North America Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Continuous Blood Glucose Monitoring Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Continuous Blood Glucose Monitoring Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Continuous Blood Glucose Monitoring Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Laboratories Company Details
 Table 47. Abbott Laboratories Business Overview
 Table 48. Abbott Laboratories Continuous Blood Glucose Monitoring Systems Product
 Table 49. Abbott Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 50. Abbott Laboratories Recent Development
 Table 51. F. Hoffmann-La Roche Company Details
 Table 52. F. Hoffmann-La Roche Business Overview
 Table 53. F. Hoffmann-La Roche Continuous Blood Glucose Monitoring Systems Product
 Table 54. F. Hoffmann-La Roche Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 55. F. Hoffmann-La Roche Recent Development
 Table 56. Lifescan Company Details
 Table 57. Lifescan Business Overview
 Table 58. Lifescan Continuous Blood Glucose Monitoring Systems Product
 Table 59. Lifescan Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 60. Lifescan Recent Development
 Table 61. Ascensia Diabetes Care Company Details
 Table 62. Ascensia Diabetes Care Business Overview
 Table 63. Ascensia Diabetes Care Continuous Blood Glucose Monitoring Systems Product
 Table 64. Ascensia Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 65. Ascensia Diabetes Care Recent Development
 Table 66. Dexcom Company Details
 Table 67. Dexcom Business Overview
 Table 68. Dexcom Continuous Blood Glucose Monitoring Systems Product
 Table 69. Dexcom Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 70. Dexcom Recent Development
 Table 71. Medtronic Company Details
 Table 72. Medtronic Business Overview
 Table 73. Medtronic Continuous Blood Glucose Monitoring Systems Product
 Table 74. Medtronic Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 75. Medtronic Recent Development
 Table 76. Ypsomed Company Details
 Table 77. Ypsomed Business Overview
 Table 78. Ypsomed Continuous Blood Glucose Monitoring Systems Product
 Table 79. Ypsomed Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 80. Ypsomed Recent Development
 Table 81. B. Braun Melsungen Company Details
 Table 82. B. Braun Melsungen Business Overview
 Table 83. B. Braun Melsungen Continuous Blood Glucose Monitoring Systems Product
 Table 84. B. Braun Melsungen Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 85. B. Braun Melsungen Recent Development
 Table 86. Nipro Company Details
 Table 87. Nipro Business Overview
 Table 88. Nipro Continuous Blood Glucose Monitoring Systems Product
 Table 89. Nipro Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 90. Nipro Recent Development
 Table 91. Sanofi Company Details
 Table 92. Sanofi Business Overview
 Table 93. Sanofi Continuous Blood Glucose Monitoring Systems Product
 Table 94. Sanofi Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 95. Sanofi Recent Development
 Table 96. Arkray Company Details
 Table 97. Arkray Business Overview
 Table 98. Arkray Continuous Blood Glucose Monitoring Systems Product
 Table 99. Arkray Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 100. Arkray Recent Development
 Table 101. Prodigy Diabetes Care Company Details
 Table 102. Prodigy Diabetes Care Business Overview
 Table 103. Prodigy Diabetes Care Continuous Blood Glucose Monitoring Systems Product
 Table 104. Prodigy Diabetes Care Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 105. Prodigy Diabetes Care Recent Development
 Table 106. Acon Laboratories Company Details
 Table 107. Acon Laboratories Business Overview
 Table 108. Acon Laboratories Continuous Blood Glucose Monitoring Systems Product
 Table 109. Acon Laboratories Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 110. Acon Laboratories Recent Development
 Table 111. Nova Biomedical Company Details
 Table 112. Nova Biomedical Business Overview
 Table 113. Nova Biomedical Continuous Blood Glucose Monitoring Systems Product
 Table 114. Nova Biomedical Revenue in Continuous Blood Glucose Monitoring Systems Business (2020-2025) & (US$ Million)
 Table 115. Nova Biomedical Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Continuous Blood Glucose Monitoring Systems Picture
 Figure 2. Global Continuous Blood Glucose Monitoring Systems Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Continuous Blood Glucose Monitoring Systems Market Share by Type: 2024 VS 2031
 Figure 4. Self-Monitoring Blood Glucose Systems Features
 Figure 5. Continuous Glucose Monitoring Systems Features
 Figure 6. Global Continuous Blood Glucose Monitoring Systems Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Continuous Blood Glucose Monitoring Systems Market Share by Application: 2024 VS 2031
 Figure 8. Self/Home Care Case Studies
 Figure 9. Hospital & Clinics Case Studies
 Figure 10. Continuous Blood Glucose Monitoring Systems Report Years Considered
 Figure 11. Global Continuous Blood Glucose Monitoring Systems Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Continuous Blood Glucose Monitoring Systems Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Continuous Blood Glucose Monitoring Systems Market Share by Region: 2024 VS 2031
 Figure 14. Global Continuous Blood Glucose Monitoring Systems Market Share by Players in 2024
 Figure 15. Global Top Continuous Blood Glucose Monitoring Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Blood Glucose Monitoring Systems as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Continuous Blood Glucose Monitoring Systems Revenue in 2024
 Figure 17. North America Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Continuous Blood Glucose Monitoring Systems Market Share by Country (2020-2031)
 Figure 19. United States Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Continuous Blood Glucose Monitoring Systems Market Share by Country (2020-2031)
 Figure 23. Germany Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Continuous Blood Glucose Monitoring Systems Market Share by Region (2020-2031)
 Figure 31. China Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Continuous Blood Glucose Monitoring Systems Market Share by Country (2020-2031)
 Figure 39. Mexico Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Continuous Blood Glucose Monitoring Systems Market Share by Country (2020-2031)
 Figure 43. Turkey Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Continuous Blood Glucose Monitoring Systems Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Abbott Laboratories Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 48. Lifescan Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 49. Ascensia Diabetes Care Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 50. Dexcom Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 51. Medtronic Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 52. Ypsomed Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 53. B. Braun Melsungen Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 54. Nipro Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 55. Sanofi Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 56. Arkray Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 57. Prodigy Diabetes Care Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 58. Acon Laboratories Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 59. Nova Biomedical Revenue Growth Rate in Continuous Blood Glucose Monitoring Systems Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS